Navigation Links
New topical approach to treating nail fungus circumvents problems with current therapy
Date:10/28/2008

WASHINGTON, D.C. (October 27, 2008) A novel topical therapy for nail fungus, NB-002, has demonstrated a new topical approach to healing nail fungus by penetrating skin pores and diffusing through the skin that surrounds the entire nail plate, according to a study conducted by NanoBio Corporation.

The data represent a unique approach to treating nail fungus (onychomycosis), which resists topical therapies because they cannot penetrate the nail and access the site of infection. The results were reported this morning at the 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th annual meeting in Washington, D.C.

"In testing NB-002 on human cadaver skin, we have demonstrated that the lotion permeates and then laterally diffuses across tissue plains in the epidermis and the dermis to more than 1 centimeter away from the site of application," said Susan Ciotti, Ph.D., director of formulations and research and development, and presenting author of the data.

"The average great toenail measures 22 millimeters across, so we are able to deliver NB-002 across the entire span of an infected human large toenail, a huge advance in the treatment of onychomycosis," Ciotti said.

Because of its novel mode of penetration and diffusion, NB-002 is able to achieve 50 times the minimum drug concentration required to kill the fungus in the very center of the nail bed. Only 4 micrograms per gram of tissue are required for NB-002 to kill fungal infections.

Newer, more effective therapies for nail fungus are important because onychomycosis remains a large unmet medical need, according to the NanoBio scientists. Oral systemic medications are plagued by serious hepatic and cardiac toxicity concerns, while current topical medications are not effective because they are unable to penetrate to the site of infection.

"The safe and efficient delivery of NB-002 ma
'/>"/>

Contact: Becky Levine
blevine@medthink.com
919-786-4918
MedThink Communications
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift
2. Topical oral syrup prevents early childhood caries
3. Nuvo licenses topical pain product from Paladin
4. Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing by FDA for the Treatment of Overactive Bladder
5. Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech
6. Fougera First-to-Market With Calcipotriene Topical Solution 0.005% (Rx) (Scalp Solution)
7. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
8. Topical Cream Treats Precancerous Lesions of Vulva
9. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
10. International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream
11. Summit VetPharm Introduces New Feline Topicals Vectra(TM) for Cats & Kittens and Vectra(TM) for Cats

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...mission leaves them without treatment for blood-bo..., Nov. 30 (HealthDay News) -- Many medical student...lood-borne diseases, but they often fail to alert ...f infection, a new study has found. , The resea...ical centers and found that 415 -- 59 percent -- h...
(Date:11/30/2009)..., , NEW ORLEANS, Nov. 30 /PRNewswire-USNews...mployees of the global corporation Sodexo will hol... Facilities and Maintenance headquarters, 3800 Des...le leave policy and arbitrary disciplinary policie... care for an ill family member. Sodexo employees w...
(Date:11/30/2009)..., , CHARLTON, Mass., Nov. 30 ... announce the addition of Family Practice physicia... Monika Mathur to its Charlton practice. ,, T...icians, coming from the Fallon Clinic, will soon j...althCare at Charlton medical office building under...
(Date:11/30/2009)... There is a tiny period of time between the regist...d and our conscious recognition of it ― betw...nize it as an apple. Our minds lag behind our eyes...actions to the world around us? , Some estimat... others say 500 milliseconds. A new study by Tel A...
(Date:11/30/2009)...anguage, social skills improve with specially desi...v. 30 (HealthDay News) -- A special, intensive ear...ucceeded in boosting IQ along with children,s lang...hen done in this fashion, many children are able t...ine Dawson, lead author of the study, published on...
Breaking Medicine News(10 mins):Health News:Med Students Often Fail to Report Needlestick Injuries 2Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:Now you see it, now you know you see it 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4
...y Institute Announces Results of Milken ...an Be Avoided with Proper Treatment and Prevention...UNSWICK, N.J., July 29 In a groundbreaking study,...on. In the U.S. as a whole, the cost is a staggeri...
...y, August 1, 2008 at 10 AM, WELLINGTON, Fla., Jul....QuantumMD.com ) has announced that pursuant to th...Caridad Center, Palm Beach,County,s largest free c...ntum Annual Shareholder Meeting in Orlando,Florida...
...ternists and pediatricians in the United States ar...s for young adults with complex chronic illnesses ...ings from a new national survey. , The survey, co...tricians to assess their comfort levels in treatin...
...s get people moving, study finds , , TUESD...riendly neighborhoods can help keep waistlines tri...find that two easily available census measures of ...esearcher Barbara Brown, a professor of family and...
...Take Medicines Safely, WASHINGTON, July 29 The N...ug Administration to issue a guidance for a,combin...receive their,prescription drugs. In a petition fi...unity Pharmacists,Association, the National Allian...
... a mark on the brain, by changing patterns of brai...ep and problems with attention. For one in six Ame...y bladder contractions that often trigger more fre...ee how an abnormal organ affects the whole organis...
Other Medicine News:Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 2Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 3Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 4Health News:The Quantum Group Announces Exclusive Screening of New PWeR(TM) System 2Health News:The Quantum Group Announces Exclusive Screening of New PWeR(TM) System 3Health News:Most generalists reluctant to provide primary care for young adults with chronic illness 2Health News:Most generalists reluctant to provide primary care for young adults with chronic illness 3Health News:Walkable Neighborhoods Keep the Pounds Off 2Health News:Consumer and Healthcare Groups Call for Clear, Concise Single Document From Pharmacy 2Health News:Findings on bladder-brain link may point to better treatments for problems in sleep, attention 2
(Date:11/30/2009)..., BLOOMFIELD HILLS, Mich., Nov. 30 /PRNewswire/...opping site dedicated exclusively to products appr...gs Account (FSA/HSA) claims. The site is also the...counter medications, saving shoppers up to 75 perc...ource helps cure two common healthcare headaches -...
(Date:11/30/2009)... , BOZEN, Italy, November 30 /PRNewswire/...nveil TPNstation,s development plans and product s... "Totally Automated Parenteral,Nutrition", a new k... to be,showcased at Las Vegas, ASHP (Booth # 114)....om our customers to the,TPNstation,s blueprints an...
(Date:11/30/2009)... , TEL AVIV, Israel, November 30 /PRNewsw...f the FOMRI-III(TM) dual channel microphone, the m...in functional magnetic resonance imaging,(fMRI) en...represents a major step forward for fiber,optic mi... quality ever, with,low-latency adaptive noise can...
Breaking Medicine Technology:eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Best Lawyers in America Selects Three Attorneys from Boston Law Firm Lubin 26amp 3B Meyer 58499 1Best Lawyers in America Selects Three Attorneys from Boston Law Firm Lubin 26amp 3B Meyer 58499 2Best Lawyers in America Selects Three Attorneys from Boston Law Firm Lubin 26amp 3B Meyer 58499 3Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 1Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 2Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 3Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 4Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 5Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 1Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 2Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 3Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 4Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 5
...ANCISCO, Calif., May 28 Sunesis,Pharmaceuticals, ...ng,clinical trials of voreloxin (formerly SNS-595)...ated interim data from Sunesis, ongoing Phase 2 cl...arian cancer patients will be presented,during the... Annual Meeting,being held May 30 - June 3, 2008 i...
...R) for hepatitis C and LymphoStat-B(R) for lupus o... in 2010 -,- ABthrax(TM) for inhalation anthrax on... strengthened with investments in oncology portfol...tive - - GSK to advance darapladib to Phase 3...uman Genome Sciences,Inc. (Nasdaq: HGSI ) today w...
Other Medicine Technology:Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress 2Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress 3Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 2Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 3Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 4Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 5Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 6Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 7Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 8Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 9Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 10Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 11
DataMate Mother/Father/Infant Laser Wristbands
DataMate Laser Label/Wristband Sheet
PrimeBand® Wristbands
Securline® Bar Code Band Wristbands
Medicine Products: